REFERENCES
- A. S. Affrasiabi, and L. C. Dong. (1986). Thermally reversible hydrogels. J. Control. Release 4:213–222.
- J. Berger, M. Reist, A. Chenite, O. Felt-Baeyens, J. M. Mayer, and R. Gurny. (2004). Structure and interaction in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 57:19–34.
- J. Berger, M. Reist, A. Chenite, O. Felt-Baeyens, J. M. Mayer, and R. Gurny. (2005). Pseudothermosetting chitosan hydrogels for biomedical application. Int. J. Pharm. 288:17–25.
- G. V. Betagiri, S. A. Jenkins, and D. L. Parsons. (1993). Preparation of liposomes in liposome drug delivery systems ( pp. 1–26). Lancaster, PA: Technomic publishing Co. Inc.
- A. Bochot, E. Fattal, A. Gulik, G. Couarraze, and P. Couvreur. (1998). Liposomes dispersed within a thermosensitive gel; a new dosage form for ocular delivery of oligonucleotides. Pharm. Res. 15:1364–1369.
- A. Chenite, M. Buschmann, D. Wang, C. Chaput, and N. Kandani. (2001). Rheological characterization of thermogelling chitosan/glycerophosphate solutions. Carbohydr. Polym. 46:39–47.
- A. Chenite, C. Chaput, D. Wang, C. Combes, M. D. Buschmann, C. D. Hoemann, J. C. Leroux, B. L. Atkinson, F. Binette, and A. Selmani. (2000). Novel injectable neutral solution of chitosan form biodegradable gels in situ. Biomaterials 21:2155–2161.
- R. E. Eliaz, and J. Kost. (2000). Characterization of polymeric PLGA-injectable implant delivery system for the controlled release of proteins. J. Biomed. Mater. Res. 50:388–396.
- O. T. Fahmy, M. A. Korani, and H. M. Maher. (2004). High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma. J. Pharm. Biomed. Anal. 34:1099–1107.
- V. Gabrijelcic, and M. Sentjurc. (1995). Influence of hydrogels on liposome stability and on the transport of liposome entrapped substances into the skin. Int. J. Pharm. 118:207–212.
- B. O. Haglund, R. Joshi, and K. J. Himmelstein. (1996). An in situ gelling system for parenteral delivery. J. Control. Release 41:229–235.
- I. Henriksen, G. Smistad, and J. Karlsen. (1994). Interactions between liposomes and chitosan. Int. J. Pharm. 101:227–236.
- B. Jeong, Y. H. Bae, D. S. Lee, and S. W. Kim. (1997). Biodegradable block copolymers as injectable drug-delivery systems. Nature 388:860–862.
- T. P. Johnston, M. A. Punjabi, and C. J. Froelich. (1992). Sustained delivery of interleukin-2 from poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm. Res. 9:425–434.
- H. H. Lin, and Y. L. Cheng. (2001). In situ thermoreversible gelation of block and star copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) of varying architectures. Macromolecules 34:3710–3715.
- G. Molinaro, J. C. Leroux, J. Damas, and A. Adam. (2002). Biocompatibility of themosensitive chitosan based hydrogels: An in vivo experimental approach to injectable biomaterials. Biomaterials 23:2717–2722.
- T. Okano, Y. H. Bae, H. Jacobs, and S. W. Kim. (1990). Thermally on-off switching polymers for drug permeation and release. J. Control. Release 11:255–265.
- N. A. Peppas, P. Bures, W. Leobandung, and H. Ichikawa. (2000). Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50:27–46.
- E. Ruel-Gariepy, A. Chenite, C. Chaput, S. Guirguis, and J. C. Leroux. (2000). Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int. J. Pharm. 203:89–98.
- E. Ruel-Gariepy, G. Leclair, P. Hildgen, A. Gupta, and J. C. Leroux. (2002). Thermosensitive chitosan based hydrogel containing liposomes for the delivery of hydrophilic molecules. J. Control. Release 82:373–383.
- M. L. Shively, B. A. Coonts, W. D. Renner, J. L. Southard, and A. T. Bennet. (1995). Physicochemical characterization of polymeric injectable implant delivery system. J. Control. Release 33:237–243.
- D. SzokaJr.. (1980). Papahadjopoulos, comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev. Biophys. Bioeng. 9:467–508.